Patents by Inventor Chin-Joo Goh

Chin-Joo Goh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vivo stimulation of cellular material
    Patent number: 8672826
    Abstract: The present invention relates to the in vivo stimulation of cellular material. In particular, the present invention relates to a method for stimulating cells and tissue in vivo comprising the step of applying to said cells and tissue an electrobiomimetic stimulus, wherein the growth characteristics of said cells and tissue are enhanced as compared to cells and tissue not receiving said stimulus.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: March 18, 2014
    Assignee: Global Energy Medicine Pty. Ltd.
    Inventors: Jeffrey David Edwards, Chin Joo Goh, Kay Fei Chan
  • VIVO STIMULATION OF CELLULAR MATERIAL
    Publication number: 20100261947
    Abstract: The present invention relates to the in vivo stimulation of cellular material. In particular, the present invention relates to a method for stimulating cells and tissue in vivo comprising the step of applying to said cells and tissue an electrobiomimetic stimulus, wherein the growth characteristics of said cells and tissue are enhanced as compared to cells and tissue not receiving said stimulus.
    Type: Application
    Filed: April 4, 2007
    Publication date: October 14, 2010
    Applicant: Global Energy Medicine Pty Ltd
    Inventors: Jeffrey David Edwards, Chin Joo Goh, Kay Fei Chan
  • Method and assay for HTLV
    Patent number: 5643714
    Abstract: Novel HTLV-I and HTLV-II peptides are disclosed for use in diagnostic assays for detecting and confirming HTLV-I and HTLV-II infection in human sera. The peptides are derived from analogous regions of HTLV-I and HTLV-II gp21 envelope protein, and are diagnostic of HTLV-I or HTLV-II infection. The invention also includes an assay kit and method for detecting, and discriminating between, HTLV-I and HTLV-II infection in humans.
    Type: Grant
    Filed: February 5, 1993
    Date of Patent: July 1, 1997
    Assignees: Genelabs Technologies, Inc., The Board of Trustees of the Leland Stanford Junior University
    Inventors: Kenneth G. Hadlock, Chin-Joo Goh, Steven K.H. Foung